These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 4548539

  • 1. Effects of a decarboxylase inhibitor on the Dopa and 5-HTP induced changes in the locomotor-like discharge pattern of rabbit hind limb nerves.
    Viala D, Buser P.
    Psychopharmacologia; 1974; 40(3):225-33. PubMed ID: 4548539
    [No Abstract] [Full Text] [Related]

  • 2. The action L-dopa on sexual behaviour of male rats.
    Da Prada M, Carruba M, Saner A, O'Brien A, Pletscher A.
    Brain Res; 1973 Jun 15; 55(2):383-9. PubMed ID: 4541349
    [No Abstract] [Full Text] [Related]

  • 3. Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.
    Butcher LL, Engel J, Fuxe K.
    Brain Res; 1972 Jun 22; 41(2):387-411. PubMed ID: 4402607
    [No Abstract] [Full Text] [Related]

  • 4. The effects of DOPA and 5-HTP on rhythmic efferent discharges in hind limb nerves in the rabbit.
    Viala D, Buser P.
    Brain Res; 1969 Feb 22; 12(2):437-43. PubMed ID: 5306638
    [No Abstract] [Full Text] [Related]

  • 5. Participation of dopamine- and serotonin- receptors in the disaggregation of brain polysomes by L-dopa and L-5-HTP.
    Weiss BF, Liebschutz JL, Wurtman RJ, Munro HN.
    J Neurochem; 1975 Jun 22; 24(6):1191-5. PubMed ID: 1079238
    [No Abstract] [Full Text] [Related]

  • 6. Effect of a decarboxylase inhibitor (Ro 4-4602) on 5-HTP induced muricide blockade in rats.
    Bocknik SE, Kulkarni AS.
    Neuropharmacology; 1974 Apr 22; 13(4):279-81. PubMed ID: 4546783
    [No Abstract] [Full Text] [Related]

  • 7. DOPA effects on motility in mice; potentiation by MK 485 and dexchlorpheniramine.
    Strömberg U.
    Psychopharmacologia; 1970 Aug 19; 18(1):58-67. PubMed ID: 5535577
    [No Abstract] [Full Text] [Related]

  • 8. 5-Hydroxytryptophan reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
    Boggan WO, Seiden LS.
    Physiol Behav; 1973 Jan 19; 10(1):9-12. PubMed ID: 4540511
    [No Abstract] [Full Text] [Related]

  • 9. Action of probenecid on the central nervous system of the rabbit. II. Potentiation of 5-hydroxytryptophan-induced hyperthermia and suppression of this effect by a decarboxylase inhibitor (Ro4-4602).
    Gardey-Levassort C, Olive G, Lechat P.
    Pharmacology; 1974 Jan 19; 11(5):267-77. PubMed ID: 4546714
    [No Abstract] [Full Text] [Related]

  • 10. Spectrum analysis of electroencephalographic changes induced by some psychoactive agents. Their possible relationship to changes in cerebral biogenic amine levels.
    Eidelberg E, Miller MK, Long M.
    Int J Neuropharmacol; 1966 Jan 19; 5(1):59-74. PubMed ID: 4380483
    [No Abstract] [Full Text] [Related]

  • 11. The role of brain 5-hydroxytryptamine in the central action of L-DOPA.
    Maj J, Pawlowski L, Sarnek J.
    Adv Biochem Psychopharmacol; 1974 Jan 19; 10():253-6. PubMed ID: 4846541
    [No Abstract] [Full Text] [Related]

  • 12. L-DOPA: centrally mediated emission of seminal fluid in male rats.
    Friedman E, Gershon S.
    Life Sci I; 1972 May 01; 11(9):435-40. PubMed ID: 4656863
    [No Abstract] [Full Text] [Related]

  • 13. Further studies on the behavioural and biochemical interaction between caffeine and L-DOPA.
    Strömberg U, Waldeck B.
    J Neural Transm; 1973 May 01; 34(4):241-52. PubMed ID: 4359657
    [No Abstract] [Full Text] [Related]

  • 14. An analysis of DOPA-induced locomotor stimulation in mice with inhibited extracerebral decarboxylase.
    Przegaliński E, Kleinrok Z.
    Psychopharmacologia; 1972 May 01; 23(3):279-88. PubMed ID: 4260342
    [No Abstract] [Full Text] [Related]

  • 15. Aterial blood pressure in dogs: effects of m-tyrosine alone or in combination with inhibitors of aromatic amino acid decarboxylase; relative hypotensive potencies of L-dopa, DL-m-tyrosine, and L-m-tyrosine.
    Minsker DH, Stokes AL.
    Experientia; 1974 Sep 15; 30(9):1051-3. PubMed ID: 4412113
    [No Abstract] [Full Text] [Related]

  • 16. Effects of L-dopa on efflux of cerebral monoamines from synaptosomes.
    Ng KY, Colburn RW, Kopin IJ.
    Nature; 1971 Apr 02; 230(5292):331-2. PubMed ID: 5549411
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of a minor pathway of L-dopa metabolism in the intestinal lumen using a decarboxylase inhibitor (Ro 4-4602).
    Bakke OM, Scheline RR.
    J Pharm Pharmacol; 1974 May 02; 26(5):377-9. PubMed ID: 4152920
    [No Abstract] [Full Text] [Related]

  • 18. Microdialysis monitoring of 3,4-dihydroxyphenylalanine accumulation after decarboxylase inhibition: a means to estimate in vivo changes in tyrosine hydroxylase activity of the rat locus ceruleus.
    Robert F, Lambás-Señas L, Ortemann C, Pujol JF, Renaud B.
    J Neurochem; 1993 Feb 02; 60(2):721-9. PubMed ID: 8093483
    [Abstract] [Full Text] [Related]

  • 19. An unexpected effect of L-5 hydroxytryptophan-ethyl-ester combined with a peripheral decarboxylase inhibitor on human serum prolactin.
    van Praag HM, Korf J, Lequin RM.
    Psychopharmacol Commun; 1976 Feb 02; 2(5-6):369-78. PubMed ID: 1088302
    [Abstract] [Full Text] [Related]

  • 20. Brain DOPA-5-HTP decarboxylase activity after the chronic administration of L-dopa or 5-hydroxy-L-tryptophan in normal and lesioned cats.
    Roberge AG, Poirier LJ.
    Brain Res; 1974 Aug 23; 76(3):401-12. PubMed ID: 4546739
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.